Home / Going-concern warnings / ImmunityBio, Inc.
Filed 2025-08-05 路 Form 10-Q 路 Accession 0001326110-25-000114 mid
Price before filing: $2.41 (2025-08-04 close, split/dividend-adjusted)
Market cap at flag: $2.28B (2025-08-05) 路 Latest: $9.64B (2026-10-16)
| Window | IBRX | SPY | vs SPY | |
|---|---|---|---|---|
| 30 days | -0.8% | +2.8% | -3.7% | 2025-09-04 |
| 90 days | -6.2% | +8.6% | -14.8% | 2025-11-03 |
| 180 days | +154.4% | +10.8% | +143.5% | 2026-02-02 |
| 1 year | +200.8% | +23.3% | +177.5% | 2026-08-05 |
Return from the last close before the filing date to the first close on/after the window end. Pending windows have not fully elapsed. Past performance says nothing certain about the future.
"As a result of continuing anticipated operating cash outflows as we commercialize our approved product and accelerate our development efforts, we believe that substantial doubt exists regarding our ability to continue as a going concern without additional funding or financial support."
Quoted from the filing. Source
The filing states that substantial doubt exists about the company's ability to continue as a going concern: it may not have enough cash to last the next 12 months. Expect dilution, debt deals or worse. An auditor's going-concern paragraph is the strongest form of this warning.
Source: management disclosure in Form 10-Q (period 2025-06-30)
Why this score: quarterly (unaudited) disclosure
Read the original filing on SEC.gov →
🔔 Get email alerts for this company
Not investment advice. Automated summary; verify against the filing.
The week's most serious auditor changes, restatements, late filings and going-concern warnings, in plain English. Free. Unsubscribe anytime.
Subscribe to the newsletter →
The signup form didn't load here (often an ad or privacy blocker). This opens beehiiv's secure signup page.
Form not showing? Subscribe on beehiiv →
Newsletter delivered by beehiiv. See our privacy policy.